"Not only is LymPro a consistent and reliable tool
Post# of 30028
Posted On: 01/15/2015 6:58:51 AM
"Not only is LymPro a consistent and reliable tool in diagnosing Alzheimer's disease, having completed 'Fit-for-Purpose' assay validation at Icon, it may now be used to enrich inclusion criteria in pharmaceutical clinical studies," said Colin Bier, Chief Development Officer of Amarantus Diagnostics, the company's newly created wholly-owned subsidiary.
already wholly owned subsidiary.. like it
already wholly owned subsidiary.. like it
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼